Safety and Efficacy of Ledipasvir/Sofosbuvir in a Genotype 1 HCV Infected Chinese Population: Results from a Phase 3, Clinical Trial

被引：0

作者：

Wei, Lai ^{[1
]}

Xie, Qing ^{[2
]}

Hou, Jinlin ^{[3
]}

Tang, Hong ^{[4
]}

Ning, Qin ^{[5
]}

Cheng, Jun ^{[6
]}

Nan, Yuemin ^{[7
]}

Zhang, Lunli ^{[8
]}

Li, Jun ^{[9
]}

Jiang, Jianning ^{[10
]}

McNabb, Brian L. ^{[11
]}

Zhang, Fangqiu ^{[12
]}

Camus, Gregory ^{[13
]}

Mo, Hongmei ^{[13
]}

McNally, John ^{[11
]}

Brainard, Diana M. ^{[11
]}

Subramanian, Mani ^{[11
]}

Gong, Guozhong ^{[14
]}

Mou, Zhuangbo ^{[15
]}

Wu, Shanming ^{[16
]}

Wang, Qui-Qiang ^{[17
]}

Hu, Peng ^{[18
]}

Gao, Yanhang ^{[19
]}

Jia, Jidong ^{[20
]}

Duan, Zhongping ^{[21
]}

机构：

[1] Peking Univ, Peoples Hosp, Beijing, Peoples R China

[2] Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai, Peoples R China

[3] Southern Med Univ, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China

[4] Sichuan Univ, West China Hosp, Chengdu, Sichuan, Peoples R China

[5] Huanzhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Hubei, Peoples R China

[6] Capital Med Univ, Beijing Ditan Hosp, Beijing, Peoples R China

[7] Hebei Med Univ, Hosp 3, Shijiazhuang, Hebei, Peoples R China

[8] Nanchang Univ, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China

[9] Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China

[10] Guangxi Med Univ, Affiliated Hosp 1, Guangxi, Peoples R China

[11] Gilead Sci Inc, Clin Res, 353 Lakeside Dr, Foster City, CA 94404 USA

[12] Gilead Sci Inc, Biostat, 353 Lakeside Dr, Foster City, CA 94404 USA

[13] Gilead Sci Inc, Virol, 353 Lakeside Dr, Foster City, CA 94404 USA

[14] Cent S Univ, Xiangya Hosp 2, Changsha, Hunan, Peoples R China

[15] Jinan Infect Dis Hosp, Jinan, Shandong, Peoples R China

[16] Clin Ctr Shanghai Publ Hlth, Shanghai, Peoples R China

[17] Peking Univ, Hosp 1, Beijing, Peoples R China

[18] Chongqing Med Univ, Affiliated Hosp 2, Chongqing, Peoples R China

[19] Jilin Univ, Hosp 1, Changchun, Jilin, Peoples R China

[20] Capital Med Univ, Beijing Friendship Hosp, Beijing, Peoples R China

[21] Capital Med Univ, Beijing Youan Hosp, Beijing, Peoples R China

来源：

HEPATOLOGY | 2017年 / 66卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1191

引用

页码：642A / 642A

页数：1

共 50 条

[1] Safety and Efficacy of Sofosbuvir/Velpatasvir in a Genotype 1-3 HCV Infected Russian and Swedish Population: Results from a Phase 3, Prospective Trial
Weiland, Ola
Zhdanov, Konstantin
Chulanov, Vladimir P.
McNabb, Brian L.
Lu, Sophia
Svarovskaia, Evguenia S.
McNally, John
Brainard, Diana M.
Subramanian, Mani
Abdurakhmanov, Dzhamal
Isakov, Vasily
HEPATOLOGY, 2017, 66 : 639A - 639A
[2] Safety and Efficacy of Sofosbuvir/Velpatasvir in a Genotype 1-6 HCV Infected Population from Singapore, Malaysia, Thailand, and Vietnam: Results from a Phase 3, Clinical Trial
Lim, Seng Gee
Mohamed, Rosmawati
Le, Phuong
Tee, Hoi Poh
McNabb, Brian L.
Lu, Sophia
Lu, Julia
McNally, John
Brainard, Diana M.
Subramanian, Mani
Tan, Chee-Kiat
Tanwandee, Tawesak
Kinh Nguyen Van
Piratvisuth, Teerha
HEPATOLOGY, 2017, 66 : 586A - 586A
[3] SAFETY AND EFFICACY OF SOFOSBUVIR/VELPATASVIR IN A GENOTYPE 1-6 HCV INFECTED POPULATION FROM SINGAPORE, MALAYSIA, THAILAND, AND VIETNAM: RESULTS FROM A PHASE 3, CLINICAL TRIAL
Lim, Seng Gee
Mohamed, Rosmawati
Phuong Le
Tee, Hoi Poh
McNabb, Brian
Lu, Sofia
Lu, Julia
McNally, John
Brainard, Diana M.
Subramanian, G. Mani
Yip, Christina Sze Man
Huang, Hai Cheng
Tan, Chee Kiat
Tanwandee, Tawesak
Kinh Nguyen Van
Piratvisuth, Teerha
GUT, 2018, 67 : A100 - A100
[4] Safety and Efficacy of Sofosbuvir/Velpatasvir in Genotype 1-6 HCV-Infected Patients in China: Results from a Phase 3 Clinical Trial
Wei, Lai
Xie, Qing
Huang, Yan
Wu, Shanming
Xu, Min
Tang, Hong
Cheng, Jun
Gao, Yanhang
Mou, Zhuangbo
Dou, Xiaoguang
Nan, Yuemin
Ning, Qin
Mao, Yimin
Stamm, Luisa
Lu, Sophia
Dvory-Sobol, Hadas
Mo, Hongmei
Brainard, Diana
Yang, Yongfeng
Wang, Guiqiang
Hu, Peng
Zhang, Lunli
Gao, Zhiliang
Lin, Feng
Shang, Jia
Gong, Guozhong
Li, Jun
Su, Minghua
Duan, Zhongping
Hou, Jinlin
Jia, Jidong
HEPATOLOGY, 2018, 68 : 379A - 379A
[5] Efficacy and safety of ledipasvir/sofosbuvir therapy in HCV genotype 1 Korean patients
Kang, Wonseok
Sinn, Dong Hyun
Gwak, Geum-Youn
Paik, Yong-Han
Choi, Moon Seok
Lee, Joon Hyeok
Koh, Kwang Cheol
Paik, Seung Woon
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 194 - 194
[6] Retreatment efficacy and predictors of ledipasvir plus sofosbuvir to HCV genotype 1 in Japan
Akuta, Norio
Sezaki, Hitomi
Suzuki, Fumitaka
Fujiyama, Shunichiro
Kawamura, Yusuke
Hosaka, Tetsuya
Kobayashi, Masahiro
Kobayashi, Mariko
Saitoh, Satoshi
Suzuki, Yoshiyuki
Arase, Yasuji
Ikeda, Kenji
Kumada, Hiromitsu
JOURNAL OF MEDICAL VIROLOGY, 2017, 89 (02) : 284 - 290
[7] Efficacy and safety of sofosbuvir and ledipasvir in the treatment of elderly Japanese patients with hepatitis C genotype 1 infected
Nagata, Kenji
Hasuike, Satoru
Takaishi, Yuuka
Yamada, Yuuri
Tsuchimochi, Mai
Nakamura, Kennichi
Shimoda, Kazuya
Sueta, Mitsue
Kusumoto, Kazunori
Ochiai, Toshimasa
Kato, Junya
Komada, Naoto
Oozono, Yoshinori
Hirono, Shuichi
Kuroki, Kazuo
Shigehira, Masafumi
Shimoda, Kazuya
HEPATOLOGY, 2016, 64 : 953A - 953A
[8] High Efficacy of Sofosbuvir/Ledipasvir for the Treatment of HCV Genotype 1 in Patients Coinfected With HIV on or off Antiretroviral therapy: Results from The NIAID ERADICATE Trial
Townsend, Kerry S.
Osinusi, Anu
Nelson, Amy K.
Kohli, Anita
Gross, Chloe
Polis, Michael A.
Pang, Phillip S.
Sajadi, Mohammad M.
Subramanian, Mani
McHutchison, John G.
Masur, Henry
Kottilil, Shyam
HEPATOLOGY, 2014, 60 : 240A - 241A
[9] Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients
Pol, Stanislas
Bourliere, Marc
Lucier, Sandy
Hezode, Christophe
Dorival, Celine
Larrey, Dominique
Bronowicki, Jean-Pierre
Ledinghen, Victor D. E.
Zoulim, Fabien
Tran, Albert
Metivier, Sophie
Zarski, Jean-Pierre
Samuel, Didier
Guyader, Dominique
Marcellin, Patrick
Minello, Anne
Alric, Laurent
Thabut, Dominique
Chazouilleres, Olivier
Riachi, Ghassan
Bourcier, Valerie
Mathurin, Philippe
Loustaud-Ratti, Veronique
D'Alteroche, Louis
Fouchard-Hubert, Isabelle
Habersetzer, Francois
Causse, Xavier
Geist, Claire
Rosa, Isabelle
Gournay, Jerome
Saillard, Eric
Billaud, Eric
Petrov-Sanchez, Ventzislava
Diallo, Alpha
Fontaine, Helene
Carrat, Fabrice
JOURNAL OF HEPATOLOGY, 2017, 66 (01) : 39 - 47
[10] Safety of Ledipasvir/Sofosbuvir with and without Ribavirin for the Treatment of Patients with Chronic HCV Genotype 1 Infection: An Analysis of the Phase 3 ION trials
Alqahtani, Saleh
Afdhal, Nezam H.
Zeuzem, Stefan
Gordon, Stuart C.
Mangia, Alessandra
Kwo, Paul Y.
Yang, Jenny C.
Ding, Xiao
Pang, Phillip S.
McHutchison, John G.
Marcellin, Patrick
Kowdley, Kris V.
Sulkowski, Mark S.
HEPATOLOGY, 2014, 60 : 1140A - 1141A

← 1 2 3 4 5 →